{
  "id": "5c654c14e842deac67000025",
  "type": "yesno",
  "question": "Does lucatumumab bind to CD140?",
  "ideal_answer": "No, lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22475052"
  ],
  "snippets": [
    {
      "text": "Lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22475052",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22475052",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Saturation of CD40 receptor on CLL cells was uniform at all doses post-treatment but also persisted at trough time points in the 3.0 mg/kg or greater cohorts.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22475052",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}